Bharat Biotech

Ocugen Reverses Course From Monday's Massive Surge As COVID-19 Vaccine Partner Faces WHO Setback

Ocugen Stock Strikes Massive Gains Day Ahead Of Key Date: What You Should Know

Is This Going To Be The Next Big Factor For Ocugen (OCGN) Stock?

Ocugen Stock Strikes Massive Gains Day Ahead Of Key Date: What You Should Know

Is This Going To Be The Next Big Factor For Ocugen (OCGN) Stock?

Why Did Ocugen Stock Skyrocket On Monday?

This 28% Short Biotech Company Has A Better 1-Year Return Than AMC, Snap, Apple And Tesla

Why Did Ocugen Stock Skyrocket On Monday?

This 28% Short Biotech Company Has A Better 1-Year Return Than AMC, Snap, Apple And Tesla

What's Going On With Ocugen (OCGN) Stock Today?

Ocugen's COVID-19 Vaccine Partner To Charge Twice As Much As Main Indian Rival Astrazeneca

Bharat Biotech Recent News

Why Ocugen Shares Skyrocketed Today

Ocugen Inc (NASDAQ: OCGN) shares soared 42.9% in the regular session and another 11% in the after-hours session on Thursday.

Ocugen's Partner Bharat Biotech Ramping Manufacturing To Produce 700M COVID-19 Vaccine Doses Annually

India's Bharat Biotech has announced COVAXIN capacity expansion to support vaccination campaigns in India and globally amid increased COVID-19 infection cases.

Ocugen Skyrockets On $23M Capital Raise Issued On 46% Premium

Why Ocugen Stock Is Trading 74% Higher Today

Ocugen Inc (NASDAQ: OCGN) shares traded 74.1% higher at $9.14 at press time in the pre-market session on Monday.